NASDAQ:VIVO
Meridian Bioscience, Inc.
- Stock
Last Close
33.97
30/01 21:00
Market Cap
1.49B
Beta: -
Volume Today
5.63M
Avg: 686.61K
PE Ratio
−551.87
PFCF: 42.66
Sep '13 | Sep '14 | Sep '15 | Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 188.69M - | 188.83M 0.08% | 194.83M 3.18% | 196.08M 0.64% | 200.77M 2.39% | 213.57M 6.38% | 201.01M 5.88% | 253.67M 26.19% | 317.90M 25.32% | 333.02M 4.76% | |
cost of revenue | 67.64M - | 71.59M 5.84% | 72.95M 1.90% | 68.30M 6.38% | 75.94M 11.19% | 83.11M 9.44% | 82.69M 0.51% | 97.42M 17.81% | 116.75M 19.84% | 144.66M 23.91% | |
gross profit | 121.04M - | 117.24M 3.14% | 121.88M 3.96% | 127.79M 4.84% | 124.83M 2.31% | 130.46M 4.51% | 118.33M 9.30% | 156.25M 32.05% | 201.15M 28.74% | 188.36M 6.36% | |
selling and marketing expenses | 22.42M - | 24.91M 11.09% | 25.60M 2.77% | 29.87M 16.68% | 32.10M 7.47% | 34.47M 7.37% | 28.45M 17.47% | 26.49M 6.89% | 26.78M 1.11% | 31.27M 16.78% | |
general and administrative expenses | 30.52M - | 27.39M 10.26% | 27.62M 0.83% | 30.57M 10.68% | 33.04M 8.10% | 34.49M 4.38% | 34.59M 0.28% | 46.42M 34.23% | 52.34M 12.75% | 57.15M 9.18% | |
selling general and administrative expenses | 52.94M - | 52.30M 1.22% | 53.22M 1.76% | 60.44M 13.57% | 65.14M 7.79% | 68.96M 5.85% | 63.03M 8.59% | 72.91M 15.67% | 79.12M 8.52% | 88.42M 11.75% | |
research and development expenses | 10.79M - | 12.55M 16.36% | 12.61M 0.42% | 13.81M 9.60% | 15.68M 13.50% | 16.87M 7.59% | 17.95M 6.39% | 23.73M 32.21% | 23.91M 0.77% | 24.34M 1.77% | |
other expenses | 4.60M - | -350K 107.62% | |||||||||
cost and expenses | 131.37M - | 136.44M 3.86% | 138.77M 1.71% | 142.55M 2.72% | 156.76M 9.97% | 168.94M 7.77% | 163.67M 3.12% | 194.06M 18.57% | 224.38M 15.62% | 257.07M 14.57% | |
operating expenses | 63.73M - | 64.85M 1.76% | 65.82M 1.50% | 74.25M 12.81% | 80.82M 8.85% | 85.83M 6.19% | 80.98M 5.65% | 96.64M 19.34% | 107.63M 11.37% | 112.41M 4.44% | |
interest expense | 897K - | 1.64M 83.05% | 1.52M 7.43% | 1.95M 27.96% | 2.63M 35.32% | 1.88M 28.65% | 1.19M 36.69% | ||||
ebitda | 62.98M - | 57.67M 8.44% | 60.28M 4.53% | 58.17M 3.51% | 46.19M 20.59% | 39.82M 13.78% | 43.47M 9.15% | 75.49M 73.68% | 107.61M 42.55% | 72.02M 33.08% | |
operating income | 57.31M - | 52.39M 8.59% | 56.06M 7.00% | 51.38M 8.35% | 37.38M 27.24% | 31.58M 15.51% | 32.70M 3.53% | 61.32M 87.54% | 93.03M 51.71% | 55.51M 40.34% | |
depreciation and amortization | 5.62M - | 5.56M 1.08% | 5.22M 6.18% | 6.63M 27.00% | 8.12M 22.50% | 7.92M 2.39% | 9.96M 25.74% | 13.57M 36.16% | 15.29M 12.67% | 16.51M 8.01% | |
total other income expenses net | 48K - | -284K 691.67% | -997K 251.06% | -734K 26.38% | -953K 29.84% | -1.20M 26.34% | -1.14M 5.15% | -2.03M 77.85% | -2.58M 27.18% | -1.19M 53.97% | |
income before tax | 57.36M - | 52.11M 9.16% | 55.06M 5.67% | 50.64M 8.03% | 36.43M 28.07% | 30.38M 16.60% | 31.56M 3.87% | 59.29M 87.89% | 90.45M 52.55% | 54.32M 39.95% | |
income tax expense | 19.33M - | 17.36M 10.17% | 19.52M 12.43% | 18.41M 5.68% | 14.87M 19.24% | 6.53M 56.09% | 7.17M 9.86% | 13.11M 82.68% | 19.04M 45.30% | 11.86M 37.73% | |
net income | 38.03M - | 34.74M 8.65% | 35.54M 2.29% | 32.23M 9.32% | 21.56M 33.11% | 23.85M 10.63% | 24.38M 2.23% | 46.19M 89.43% | 71.41M 54.61% | 42.46M 40.54% | |
weighted average shs out | 41.23M - | 41.45M 0.56% | 41.66M 0.49% | 42.01M 0.84% | 42.19M 0.42% | 42.75M 1.34% | 42.90M 0.34% | 43.17M 0.64% | 44.01M 1.94% | 44.01M 0% | |
weighted average shs out dil | 41.90M - | 41.91M 0.04% | 42.01M 0.24% | 42.39M 0.91% | 42.57M 0.42% | 42.75M 0.43% | 42.90M 0.34% | 43.17M 0.64% | 44.01M 1.94% | 44.01M 0% | |
eps | 0.92 - | 0.84 8.70% | 0.85 1.19% | 0.77 9.41% | 0.51 33.77% | 0.56 9.80% | 0.57 1.79% | 1.07 87.72% | 1.62 51.40% | 0.96 40.74% | |
epsdiluted | 0.91 - | 0.83 8.79% | 0.85 2.41% | 0.76 10.59% | 0.51 32.89% | 0.56 9.80% | 0.57 1.79% | 1.07 87.72% | 1.62 51.40% | 0.96 40.74% |
All numbers in USD (except ratios and percentages)